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To characterize the type of genetic alterations in gastro-
intestinal stromal tumors (GISTs), we performed a compre-
hensive allelotype study of 14 GISTs (2 benign, 7 borderline
and 5 malignant) by polymerase-chain-reaction and loss-of-
heterozygosity (PCR-LOH) analysis using 102 microsatellite
markers, and compared the results with comparative-
genomic-hybridization (CGH) analysis. Among the 38 evalu-
ated chromosomal arms, 16 (42.1%) showed LOH in at least
one patient. Most frequent LOH was observed at chromo-
some 14p and 14q (9/14, 64%) and this was demonstrated in
all types of GISTs (50% in benign, 71% in borderline and 80%
in malignant). Additional chromosomal deletions were found
in several chromosomal arms. Among them, deletions on
chromosomal arms of 22q (3/14, 21.4%), 9p (2/14, 14.3%) and
9q (2/14, 14.3%) were the most frequent, and were detected
only in malignant GISTs both by PCR-LOH and by CGH
analysis. Additionally, 2 malignant GISTs with LOH on 9p
showed homozygous deletions in the restricted area of 9p by
multiplex PCR-LOH analysis. Thus, several putative chromo-
somal changes were preferentially present in malignant
GISTs but rare in benign and borderline GISTs. These find-
ings suggest that accumulated chromosomal changes may
contribute to the progression and/or malignant transforma-
tion of GISTs. Int. J. Cancer 85:633–638, 2000.
© 2000 Wiley-Liss, Inc.
Most gastrointestinal mesenchymal tumors are composed of
uncommitted mesenchymal cells and are designated as gastroin-
testinal stromal tumors (GISTs) (Lewin et al., 1992; Appelman,
1998). GISTs have been the subject of considerable controversy
and debate in the literature regarding their histogenesis, criteria for
diagnosis, prognostic features and nomenclature (Lewin et al.,
1992; Appelman, 1998; Hjermstad et al., 1987). Immunohisto-
chemical studies have shown GISTs to be characteristically CD34-
and c-kit-positive, and negative or variably positive for the other
neural and smooth-muscle-cell markers (Kindblom et al., 1998;
Miettinen et al., 1995). The expression of c-kit and CD34 is the
characteristic feature of the intestinal cell of Cajal (ICC) located in
and near the circular muscle layer of the stomach and intestine. On
the basis of the studies cited, it has been suggested that these
tumors originate from stem cells that differentiate toward ICC
because of the morphological and immunohistochemical similari-
ties between ICC and GISTs (Kindblom et al., 1998; Hirota et al.,
1998).
The results of molecular genetic changes related to GISTs have
been rapidly accumulating. DNA aneuploidy, gain-of-function
mutations of the c-kit proto-oncogene (Hirota et al., 1998; Nishida
et al., 1998; Nakahara et al., 1998; Lasota et al., 1999; Moskaluk
et al., 1999) and frequent changes of DNA copy numbers in
chromosome 14q and 22q (El-Rifai et al., 1996; Sarlomo-Rikala et
al., 1998) have been found in GISTs. Early studies for the changes
of DNA copy numbers in GISTs were analyzed by comparative
genomic hybridization (CGH) (El-Rifai et al., 1996; Sarlomo-
Rikala et al., 1998). CGH analysis is a valuable technique for
whole-genome scanning, a procedure that can identify the chro-
mosomal imbalances in entire genomes if the changes exceed 10
Mb. Although CGH study is rapid and less laborious than PCR and
loss of heterozygosity (LOH) analysis, allelotype analysis by PCR-
LOH study has the advantage of identifying small interstitial
deletions, since the microsatellite markers are highly polymorphic
and evenly distributed on the chromosomes (Dib et al., 1996).
Thus, chromosome analysis of GIST using these 2 methods and
comparing the results will give more precise information on the
specific changes of DNA copy numbers.
Among the known DNA-copy-number changes, the loss of
chromosome 14q is very common in GISTs. This change is not
found in leiomyoma or schwannoma, suggesting that GIST is a
different type of tumor from leiomyomas or schwannomas, both
phenotypically and genetically (Sarlomo-Rikala et al., 1998). Loss
of chromosome 14q is known to be frequent in benign, borderline
and malignant tumors, and is thus regarded as an early change in
GISTs (El-Rifai et al., 1996). Other genetic changes of DNA copy
numbers are relatively infrequent, and are not well characterized.
The identification of common DNA-copy-number changes and
small interstitial deletions in specific chromosomal arms in GISTs
should provide understanding of genetic changes related to the
development and progression of GIST. We therefore carried out an




Fourteen GISTs occurring in the stomach were included in this
study. All the cases were identified prospectively and consecu-
tively in the Department of Pathology at Yonsei University Med-
ical Center between September 1995 and November 1998 for a
study of molecular markers in GISTs. Information was obtained
from chart reviews and from clinicians to determine demographic
and tumor sites. The patients included 5 females and 9 males,
ranging in age from 35 to 78 years (Table I).
For DNA extraction, tumors and adjacent non-tumorous mucosal
tissues were obtained immediately after surgical excision. The se-
lected tissues were rapidly frozen in liquid nitrogen and stored at
270°C until the DNA was isolated. To enrich the tumor-cell popu-
lation, more than 90% of tumor-cell areas were selected from the
hematoxylin-eosin stained slides by the cryostat microdissection tech-
nique. Genomic DNA was prepared by the sodium-dodecyl-sulfate-
proteinase-K and phenol-chloroform extraction method.
Pathological analysis
Conventional pathologic parameters (tumor size, tumor number,
differentiation) were examined prospectively without knowledge
of the molecular data. The GISTs were divided into 3 groups
according to the criteria of Lewin et al. (1992). The guidelines for
the diagnosis of malignancy of gastric stromal tumors are com-
posed of 2 unequivocal factors (histologically confirmed metasta-
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sis, and invasion of adjacent organs) and 5 high-risk factors (larger
than 5.5 cm in diameter, more than 5 mitoses per 50 high-power
field, presence of tumor necrosis, nuclear pleomorphism, dense
cellularity, microscopic invasion of lamina propria or blood ves-
sels and the presence of alveolar or cell balls in the epithelioid
variant). Tumors having more than 1 unequivocal or 2 high-risk
features were categorized as malignant GISTs, tumors having only
1 high-risk feature were categorized as borderline (stromal tumor
of uncertain malignant potential, STUMP) and tumors having no
unequivocal or high-risk features were categorized as benign
GISTs. By these criteria, 2 cases were categorized as benign, 7
cases as STUMP and 5 cases as malignant GIST. Histologically,
10 cases were categorized as spindle-cell type and the remaining 4
cases as epithelioid-cell type.
Immunohistochemical analysis
Formalin-fixed and paraffin-embedded tissues were sectioned in
6-mm thickness. De-paraffinization and re-hydration were per-
formed using xylene and alcohol. The sections were treated with
0.3% hydrogen peroxidase for 3 min and blocking antibody for
30 min. The primary antibodies used included those to CD34
(clone QBEMD-10, 1:80 dilution; Monosan, The Netherlands),
a-smooth-muscle actin (clone HHF35, 1:50 dilution; DAKO,
Glostrup, Denmark), S100 (rabbit polyclonal, 1:1,500 dilution;
DAKO) and c-kit (rabbit polyclonal, Santa Cruz Biotechnology,
Santa Cruz, CA). Avidin-biotin-complex methodology was used.
The chromogen was diaminobenzidine and counterstaining was
done with hematoxylin. For evaluation of these gene products,
definite cytoplasmic and plasma membrane staining was regarded
as positive.
PCR-LOH analysis
A total of 102 microsatellite markers covering 38 chromosome
arms were selected and obtained from Research Genetics (Hunts-
ville, AL). They are shown in Table II. Multiplex PCR reactions
were carried out in a mixture of 20 ml containing 1.5 mM MgCl2,
20 pmol primer, 0.2 mM each dATP, dGTP, dTTP, 5 mM dCTP,
1 mCi [a-32P] dCTP (3000 Ci/mmol; NEN DuPont, Boston, MA),
50 ng of sample DNA, 13 PCR buffer and 1.25 U Taq polymerase
(GIBCO-BRL, Grand Island, NY). After de-naturation at 95°C for
5 min, DNA amplification was performed for 25 to 30 cycles
consisting of de-naturation at 95°C for 30 sec, primer annealing at
55 to 60°C for 30 sec and elongation at 72°C for 15 sec.
Amplified DNA was diluted 2-fold with stop solution (95%
formamide, 20 mM EDTA, 0.05% xylene cyanol and 0.05%
bromophenol blue). Then 3 ml of amplified product were loaded
onto 6% polyacrylamide gel containing 5.6 M urea. The gel was
dried on filter paper and exposed to Kodak XAR-5 film (Kodak,
Rochester, NY) at 270°C. LOH was scored when the band inten-
sity of one allelic marker decreased significantly (more than 70%
loss) in tumor DNA compared with that in normal DNA (Fig. 1).
LOH on each chromosome arm was further divided into high
(more than 50% of informative cases), moderate (30–50%) and
low (less than 30%) according to the frequency of allelic loss.
Fractional allelic loss (FAL) was defined as the number of chro-
mosomal arms showing allelic loss divided by the total number of
informative chromosomal arms in a tumor, as described by Vo-
gelstein et al. (1989).
Comparative genomic hybridization and digital image analysis
Comparative genomic hybridization (CGH) was performed us-
ing direct fluorochrome-conjugated dUTPs. Genomic DNA sam-
ples from tumors were labeled with Spectrum Green dUTP (Vysis,
Downers Grove, IL), and reference genomic DNA was labeled
with Spectrum Red dUTP (Vysis) by the nick-translation tech-
nique, to obtain DNA fragments ranging from 300 to 3,000 bp.
Labeled tumor and reference DNA (200–400 ng) and 10 mg of
unlabeled human Cot-1 DNA (Vysis) were ethanol-precipitated
and re-suspended in 10 ml of hybridization buffer (50% form-
amide, 10% dextran sulfate, 23 SSC). The hybridization mixture
was de-natured at 73°C for 5 min, then immediately hybridized
onto normal metaphases de-natured in 70% formamide/23 SSC at
73°C for 2 min. Hybridization was carried out at 37°C for 72 hr.
After hybridization, the slides were washed 3 times in 50% form-
amide/23 SSC (pH 7.0), 3 times in 0.23 SSC at 45°C, followed
by washes in 23 SSC, 0.23 SSC and distilled water at room
temperature for 10 min each. After drying, the slides were coun-
terstained with 49,6-diamidino-2-phenylindole dihydrochloride
(DAPI) in anti-fade solution. CGH hybridization was analyzed
with an Olympus fluorescent microscope and the Cytovision im-
age-analysis system (Applied Imaging, Sunderland, UK). The in-
dividual DAPI, Spectrum Green, Spectrum Red images were sub-
sequently captured in gray digital images from 10 to 20
methaphases in each hybridization, then digitally pseudocolored in
blue, green and red. Normal male DNA and DNA from tumor cell
lines with known aberrations were used as control test DNA.
Green-to-red intensity-ratio profiles were calculated for each chro-
mosome, and threshold values defining gains and losses were set at
1.25 and 0.75 respectively.
RESULTS
Immunohistochemical features of gastrointestinal stromal tumors
Examination of 14 gastrointestinal stromal tumors for expres-
sion of CD34 and c-kit, known reliable markers for GISTs, re-
vealed that 12 cases (86%) were positive both for CD34 and for
c-kit and the remaining 2 cases were positive for only one of these
2 markers. a-smooth-muscle actin was focally present in 3 cases
(21%), and no cases were positive for S100 protein.
TABLE I – CLINICOPATHOLOGICAL FEATURES OF GASTROINTESTINAL STROMAL TUMORS
Case
number Tumor size(cm) Tumor type Cell type Anatomic site Mitotic index
1 Immunohistochemical result
S100 a-smooth muscle CD34 c-kit
1 2.5 benign spindle body 0 2 2 1 1
2 4 benign spindle body 1 2 2 1 1
3 7 borderline spindle body 0 2 2 1 1
4 5 borderline epitheloid antrum 4 2 1 1 1
5 4 borderline spindle fundus 11 2 1 1 1
6 8 borderline spindle fundus 0 2 2 1 1
7 9 borderline spindle body 2 2 2 1 1
8 5.5 borderline epithelioid fundus 2 2 2 1 2
9 5 borderline spindle body 2 2 2 1 1
10 12 malignant spindle body 7 2 2 1 1
11 10 malignant epithelioid body 4 2 1 2 1
12 17 malignant epithelioid body 172 2 2 1 1
13 22 malignant spindle antrum 9 2 2 1 1
14 3.7 malignant spindle fundus 98 2 2 1 1
1Number of mitoses per 50 high-power field. 1, expression; 2, no expression.
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Frequency of LOH on each chromosomal arms
We screened 14 gastrointestinal stromal tumors for LOH at
every chromosomal arm with 102 microsatellite markers. The
average informativeness per marker was 68.5% (range, 9.2 to
100%). Among the 38 chromosomal arms, 18 (1p, 2q, 3p, 3q,
6q, 8p, 8q, 9p, 9q, 10p, 10q, 11p, 13q, 14p, 14q, 16p, 17p, 22q)
showed LOH for at least 1 patient, while the remaining 20
chromosomal arms (1q, 2p, 4p, 4q, 5p, 5q, 6p, 7p, 7q, 11q, 12p,
12q, 15q, 16q, 17q, 18p, 18q, 19q, 20q, 21q) showed no LOH.
Among all 14 patients, 9 (64%) showed LOH on at least 1
chromosomal arm (Table II). Representative examples of auto-
radiograms scored as LOH are shown in Figure 1. The fre-
quency of LOH on each chromosome arm is shown in Figure
2a. Frequency LOH (.50%) was found on chromosome 14
(64%) and other chromosome arms had a low LOH frequency of
less than 30%.
Fractional allelic loss
Fractional allelic loss (FAL), defined as the number of chromo-
some arms showing allelic loss divided by the total number of
informative chromosomal arms in a tumor (Vogelstein et al., 1989)
was calculated for all 14 tumors. The FAL value varied among 14
cases, ranging from 0 (0 of 37 informative arms) to 0.24 (9 of 37
informative arms) with a median value of 0.069 and a mean of
0.076, indicating that 7.6% of chromosomal arms had LOH in our
cases. The malignant GISTs showed higher FAL values than
benign and borderline GISTs (0.14 vs. 0.004, p , 0.04 by Wilc-
oxon’s rank-sum test).
Homozygous deletions on chromosome 9p
We found 2 cases of homozygous deletions in D9S1846 markers
on chromosome 9p by multiplex PCR-LOH analysis (Fig. 3). Both
cases (case 13, 14) were malignant GIST. These 2 cases showed
LOH on the entire area of 9p in one chromosomal arm and also
TABLE II – SELECTED MICROSATELLITE MARKERS AND FREQUENCY OF LOH ON EACH CHROMOSOME ARM
Chromosome arm Locus Allelic loss/informative
case (%) Chromosome arm Locus
Allelic loss/informative
case (%)
1p D1S496 10p D10S591
D1S209 1/13 (7.7) D10S191 1/14 (7.1)
1q D1S431 10q D10S185
D1S412 D10S209
D1S237 D10S1072
D1S446 0/14 D10S555 1/14 (7.1)
2p D2S165 11p D11S988
D2S123 D11S1308
D2S286 0/14 D11S935 1/14 (7.1)
2q D2S114 11q D11S918
D2S156 D11S898
D2S155 1/14 (7.1) D11S1320 0/11
3p D3S1260 12p D12S93
D3S1566 1/13 (7.7) D12S358 0/14
3q D3S1310 12q D12S85
D3S1288 1/14 (7.1) D12S327
4p D4S1608 0/8 D12S343 0/14
4q D4S411 13q D13S144
D4S1615 D13S121 2/12 (16.7)
D4S1566 14p D14S582
D4S1554 0/14 D14S152 9/14 (64.2)
5p D5S486 14q D14S281
D5S395 0/14 D14S268
5q D5S424 D14S267
D5S489 D14S51 9/14 (64.2)
D5S494 15q D15S153
D5S625 0/14 D15S211 0/14
6p D6S344 16p D16S521
D6S289 D16S292 1/14 (7.1)
D6S452 0/14 16q D16S752
6q D6S278 D16S516
D6S292 D16S505 0/13
D6S297 1/13 (7.7) 17p D17S520
7p D7S481 0/7 D17S969
7q D7S645 D17S953 1/14 (7.1)
D7S487 17q D17S250
D7S684 0/14 D17S939 0/12
8p D8S264 18p D18S40 0/12
D8S552 1/14 (7.1) 18q D18S46
8q D8S279 D18S51 0/13
D8S257 19q D19S178
D8S555 1/14 (7.1) D19S246
9p D9S162 D19S418 0/13
D9S1846 20q D20S27
D9S171 D20S108
D9S165 2/14 (14.3) D20S109
9q D9S152 D20S171 0/13
D9S280 21q D21S11
D9S176 D21S1255
D9S195 2/14 (14.3) D21S231 0/14
22q IL2RB
D22S685 3/14 (21.4)
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showed a restricted area of homozygous deletions in the other
chromosomal arm.
Chromosomal copy number aberrations by CGH analysis
CGH analysis was also performed in 14 gastrointestinal stromal
tumors. Among these, 10 stromal tumors exhibited several genetic
imbalances (range, 0–7/case; mean number 2.65/case); chromo-
somal losses were more frequent than gains. A schematic summary
of all copy number aberrations is shown in Figure 2b. The chro-
mosomal arms most often under-represented were 14q (64%, 9/14)
and 22q (21.4%, 3/14). Under-representation of 14q and 22q
involved the entire long arm in all cases affected (Fig. 2b). The
entire deletion on chromosome 14q was confirmed by PCR-LOH
study using 4 microsatellite markers.
Other commonly under-represented segments in this series were
9q (14.3%, 2/14), 9q (14.3%, 2/14) and 13q (16.7%, 2/12), and
under-representation of these chromosomal arms was also in-
volved in all chromosomal arms. In addition, under-representation
involving the entire segment of 1p and interstitial losses of 8p, 10p
and 10q were observed in only 1 case for each deletion (Fig. 2b).
Over-representation of a chromosome arm was also observed
infrequently: 3 cases in 18p and 19p, 2 cases in chromosome 4p,
4q and 22q, and 1 case in 2p, 2q, 5q11–21, 8q12–23, 12q, 16q, and
20p.
Comparison of allelotype analysis by PCR-LOH and of
chromosomal copy numbers by CGH
In our GISTs, both methods gave the same results for chromo-
somal losses. Most of the chromosomal arms with LOH showed
wide scope deletions usually covering the entire chromosomal
arms, and they were detected by CGH (Table II, Fig. 2). However,
deletions on chromosome 14p in 9 cases and 2 homozygous
deletions on 9p detected by multiplex PCR-LOH analysis were not
detected by CGH. Most of the chromosomal gains detected by
CGH presented as allelic imbalance by PCR-LOH analysis (Fig.
4); however, these were not interpreted as LOH, since LOH was
scored when one allele was almost totally missing (more than 70%
loss).
DISCUSSION
In this study, 14 cases of fresh frozen gastrointestinal stromal
tumors were investigated for the characterization of chromosomal
abnormalities by PCR-LOH and CGH methods. We confirmed
earlier findings that frequent losses on chromosome 14q were
present in most benign, borderline and malignant GISTs. In addi-
tion, we found that all the GISTs with 14q deletion also had 14p
deletion. We found additional novel losses and gains on several
chromosomal arms and homozygous deletions on chromosome 9p
in malignant GISTs.
The frequent loss of 14q was shown by CGH analysis (El-Rifai
et al., 1996), and subsequent experiment demonstrated that this
change was rare in other types of mesenchymal tumors (Sarlomo-
Rikala et al., 1998). In agreement with these reports, we demon-
strated frequent losses (9/14, 64%) on the entire long arm of
chromosome 14 in benign, borderline and malignant GISTs. How-
ever, we demonstrated that all cases with 14q deletion also had 14p
deletion by PCR-LOH analysis. The deletion of 14p was not
described in earlier chromosomal studies with CGH analysis (El-
Rifai et al., 1996; Sarlomo-Rikala et al., 1998), possibly because
CGH analysis cannot detect chromosomal changes in the satellite
chromosomal arms (Kallioniemi et al., 1994). The monosomy of
chromosome 14 was detected in one GIST by karyotype analysis
(Marci et al., 1998). The mechanism for this specific deletion of
chromosome 14 in GISTs and its role in tumor development are
unknown. Whatever the mechanism, this finding, in association
with currently reported results that most GISTs express c-kit
protein, may be useful in diagnosis.
In addition to chromosome-14 loss, we found other losses and
gains on 18 chromosome arms, but the frequency was low
(,30%). Among these changes in chromosomal arms, loss in
DNA copy numbers at 1p, 15q and 22q, and allelic gains in
chromosome 5q, 19p and 8q were reported by El-Rifai et al.
(1996). The other chromosomal changes in 12 chromosomal
arms (4q, 6q, 8p, 9p, 9q, 10q, 12q, 13q, 16q, 18p, 18q and 20p)
were detected by us. Interestingly, these alterations were absent
in benign and rare in borderline GISTs. In malignant GISTs, the
frequency of alterations in 14p, 14q and 22q was high (.50%)
and in 9p and 9q was moderate (30 to 50%), indicating that
alterations of chromosomal arms other than chromosome 14,
especially 9p, 9q and 22q, are accumulated in malignant GISTs.
These findings suggest that additional chromosomal changes
occur as late events related to tumor progression and malignant
transformation.
In agreement with other studies, most of the abnormal areas on
the chromosome were extensive, and entire chromosomal arms
were usually deleted. Among the newly found abnormal chromo-
somal areas, losses of chromosomal arms on 9p and 10q are of
particular interest. The case with 10q deletion (case 4) showed a
FIGURE 1 – Illustration of loss-of-heterozygosity analysis with microsatellite marker D14S582. The stromal tumor (T) and corresponding
non-tumoral tissue (N) are shown with microsatellite marker indicated at the bottom. Cases 1 and 2 are benign, cases 3 to 9 are borderline and
cases 10 to 14 are malignant GIST. Tumor cases 1, 4, 6, 11 and 13 exhibit loss of the upper allele. Tumor cases 5 and 14 exhibit loss of the
lower allele.
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relatively small area of deletions (10q21–26) and this area harbors
the pten gene (10q23), a tumor-suppressor gene identified by Li et
al. (1997). However, this phenomenon might be incidental, since
the incidence of loss of 10q is quite low (1/14, 7.1%) in GISTs.
Two malignant GISTs (case 13 and 14) with 9p deletion showed
the entire deletion of 9p in one chromosomal arm and had ho-
mozygous deletions in the restricted area of 9p from D9S1846 to
D9S171 encompassing 5.5 cM, corresponding approximately to a
3.71 Mb when 1 cM is expected to cover 675 kb of physical
distance (Krauter et al., 1995). Interestingly, these small areas of
homozygous deletions contain the p16INK4A gene, a well-known
tumor-suppressor gene involved in multiple human tumors (Lig-
gett and Sidransky, 1998). The present PCR-LOH study for allelo-
type analysis also shows homozygous deletions in the restricted
area of certain chromosomal arms in GISTs. The role of the
tumor-suppressor gene in malignant GIST has not yet been re-
ported. Since homozygous deletions are among the mechanisms
for complete inactivation of the tumor-suppressor gene, it can be
concluded that inactivation of p16INK4A may play a role in the
progression of some malignant GISTs.
Our allelotype study, by using multiplex PCR-LOH and CGH
analysis, permitted us to identify detailed chromosomal changes in
GISTs. The chromosomal deletions covering large areas were
identified identically in PCR-LOH and CGH analysis. However,
homozygous deletions covering a small area on 9p and the entire
deletion of chromosome 14p, one of the acrocentric chromosomal
arms, were not found in CGH analysis. Although most of the
chromosomal gains are demonstrated as allelic imbalance in PCR-
LOH analysis, the results of CGH were more objective in identi-
fying specific chromosomal gains. From these findings it can be
concluded that the use of both methods for allelotype analysis
FIGURE 2 – Results of LOH and CGH imbalance analysis. (a) Fre-
quency of LOH on each chromosomal arm in 14 gastrointestinal
stromal tumors. The microsatellite markers used are listed in Table II.
p denotes short arm and q denotes long arm. (b) Summary of CGH
imbalances detected in 14 gastrointestinal stromal tumors. Vertical
lines on the left of each chromosome idiogram represent loss of
chromosomes, whereas vertical lines on the right correspond to chro-
mosomal gains.
FIGURE 3 – Representative autoradiograph of multiplex PCR-LOH
analysis with D9S165 and D9S1846 microsatellite markers. LOH was
demonstrated in cases 13 and 14 by D9S165 markers. The homozy-
gous deletions were demonstrated by a complete loss of amplified
products with D9S1846 markers in cases 13 and 14.
FIGURE 4 – Comparison of the results of CGH and PCR-LOH anal-
yses from case 13. Green-to-red intensity ratio was calculated for each
chromosome, and threshold values defining gains and losses were set
at 1.25 and 0.75. n denotes number of metaphase chromosome images
captured after CGH. The microsatellite markers used are shown at the
bottom. Note that over-representation of chromosome 4 detected by
CGH analysis shows as allelic imbalance by PCR-LOH analysis,
whereas under-representation of chromosomes 9, 14 and 22 detected
by CGH analysis shows as the loss of one allele by PCR-LOH
analysis.
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provided more accurate evaluation of chromosomal status in tu-
mors.
In summary, a comprehensive allelotype study of GIST was
completed using PCR-LOH and CGH analysis. We have demon-
strated that the deletion of chromosome 14 is the most frequent
chromosomal alteration in GISTs. We also found several putative
chromosomal-arm alterations in malignant GISTs, while such
changes were rare in benign and borderline GISTs. Homozygous
deletions on the short arm of chromosome 9 were observed in only
2 malignant GISTs. These findings suggest that genetic changes
are accumulated during the progression of GISTs.
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